About Us News Contact Us
Login Register
Go to cart
The VBI News blog of VBI is a multi-dimensional perspective on Vietnam Business Infomation. You can find important economic news, expert’s reviews & opinion in this blog. The most updated business and financial news on Vietnam Economy with facts & figures will be covered. Readers are given critical information may affect your money while doing business in Vietnam.

Overview of Vietnam's pharmaceutical industry in 2024

Overview of Vietnam's pharmaceutical industry in 2024
Vietnam's pharmaceutical industry in 2024 stands at a significant juncture, characterized by rapid growth, evolving regulations, and increasing investment in research and development.

As one of the fastest-growing economies in Southeast Asia, Vietnam has witnessed remarkable advancements in healthcare infrastructure and access to essential medicines over the past decade.

Market growth and demand

Vietnam's population, currently over 97 million, is experiencing steady growth. The country's large and young demographic, with a median age of around 30 years, presents a significant consumer base for pharmaceutical products.

As Vietnam's economy continues to grow, so does healthcare spending. Rising income levels and expanding middle-class populations are driving increased demand for healthcare services and pharmaceutical products.

Non-communicable diseases (NCDs) such as diabetes, cardiovascular diseases, and cancer are becoming increasingly prevalent in Vietnam due to changing lifestyles, urbanization, and an aging population. This trend is fueling demand for pharmaceuticals, particularly innovative treatments and disease management therapies.

Increasingly prevalent NCDs fuel demand for pharmaceutical in Vietnam

Government initiatives and regulations

The Vietnamese government has implemented various incentives to promote investment in the pharmaceutical sector, including tax breaks, subsidies for research and development, and preferential treatment for domestic pharmaceutical companies.

Vietnam's pharmaceutical industry is regulated by the Ministry of Health (MOH) and the Drug Administration of Vietnam (DAV). The regulatory framework includes requirements for Good Manufacturing Practices (GMP), quality control standards, and product registration procedures to ensure the safety, efficacy, and quality of pharmaceutical products.

Innovation and Research & Development (R&D)

Investment in R&D: both domestic and multinational pharmaceutical companies are increasing their investment in R&D activities in Vietnam. This includes drug discovery, clinical trials, and the development of novel therapies targeting prevalent diseases in the country.

Collaboration between universities, research institutions, and pharmaceutical companies promotes innovation and accelerates the translation of research findings into viable pharmaceutical products. Public-private partnerships play a crucial role in supporting R&D initiatives.

Vietnam is investing in expanding and upgrading its healthcare infrastructure, including hospitals, clinics, and pharmacies, to enhance access to healthcare services across urban and rural areas.

Efforts to strengthen distribution networks and supply chain management improve the availability and accessibility of pharmaceutical products, particularly in remote and underserved regions.

Health Insurance Coverage: The expansion of health insurance coverage in Vietnam increases affordability and access to essential medicines for the population. Government-sponsored health insurance schemes and employer-provided health benefits contribute to healthcare financing and drug affordability.

health insurance coverage in Vietnam increases affordability and access to essential medicines

Challenges and Opportunities

Challenges related to the enforcement of intellectual property rights remain, impacting innovation and investment in the pharmaceutical sector. Strengthening IPR protection is essential to incentivize R&D and technology transfer.

The prevalence of counterfeit and substandard drugs in the market poses risks to patient safety and undermines trust in the pharmaceutical industry. Regulatory authorities are implementing measures to combat counterfeit medicines through increased surveillance and enforcement actions.

Price regulations and reimbursement policies influence market dynamics and profitability for pharmaceutical companies. Striking a balance between ensuring affordability for patients and maintaining incentives for innovation is a key challenge for policymakers.

In conclusion, Vietnam's pharmaceutical industry in 2024 is characterized by dynamic growth, driven by increasing demand, government support, and investments in innovation. Despite facing challenges such as regulatory compliance, intellectual property protection, and access to healthcare, the industry presents significant opportunities for expansion and advancement in the coming years. Collaboration among stakeholders, continued investment in R&D, and regulatory reforms will be crucial in shaping the future trajectory of Vietnam's pharmaceutical sector.


Want to know more about Vietnam's top pharmaceutical companies? Stay tuned to catch our upcoming updates.

If you already have a specific name in mind and want to find out all the related details about a particular company, look up a name in our database and explore the right type of report for your queries!

Vietnam Business Information

Profits of beer businesses saw a decline
Tuesday 06, 02 2024

Profits of beer businesses saw a decline

Beer enterprises all witnessed a decline in business results due to the...